| MeSH term | MeSH ID | Detail |
|---|---|---|
| Central Nervous System Protozoal Infections | D020808 | 3 associated lipids |
| Communicable Diseases, Emerging | D021821 | 3 associated lipids |
| Chlamydophila Infections | D023521 | 4 associated lipids |
| Pulmonary Disease, Chronic Obstructive | D029424 | 16 associated lipids |
| Desulfovibrionaceae Infections | D045824 | 5 associated lipids |
| Moraxellaceae Infections | D045828 | 3 associated lipids |
| Pyloric Stenosis, Hypertrophic | D046248 | 2 associated lipids |
| Mucositis | D052016 | 7 associated lipids |
| Tendinopathy | D052256 | 3 associated lipids |
| Male Urogenital Diseases | D052801 | 1 associated lipids |
| Pyomyositis | D052880 | 2 associated lipids |
| Hyper-IgM Immunodeficiency Syndrome | D053306 | 1 associated lipids |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | D054198 | 10 associated lipids |
| Tracheobronchomalacia | D055089 | 1 associated lipids |
| Failed Back Surgery Syndrome | D055111 | 3 associated lipids |
| Acute Lung Injury | D055371 | 33 associated lipids |
| Multiple Pulmonary Nodules | D055613 | 2 associated lipids |
| Corneal Endothelial Cell Loss | D055954 | 1 associated lipids |
| Neglected Diseases | D058069 | 3 associated lipids |
| Acute Kidney Injury | D058186 | 34 associated lipids |
| Asymptomatic Infections | D058345 | 1 associated lipids |
| Trichiasis | D058457 | 1 associated lipids |
| Granulomatous Mastitis | D058890 | 1 associated lipids |
| Reproductive Tract Infections | D060737 | 1 associated lipids |
| Chlamydial Pneumonia | D061387 | 2 associated lipids |
| Tick Bites | D064927 | 1 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Sardana K et al. | An observational study of the efficacy of azithromycin in erythema annulare centrifugum. | 2018 | Clin. Exp. Dermatol. | pmid:29297941 |
| Bakar O et al. | The effect of azithromycin on reactive oxygen species in rosacea. | 2007 | Clin. Exp. Dermatol. | pmid:17244346 |
| Trevisi P et al. | Toxic pustuloderma associated with azithromycin. | 1994 | Clin. Exp. Dermatol. | pmid:8033402 |
| Fuentelsaz V et al. | Rosacea fulminans in pregnancy: successful treatment with azithromycin. | 2011 | Clin. Exp. Dermatol. | pmid:21714808 |
| Kus S et al. | Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris. | 2005 | Clin. Exp. Dermatol. | pmid:15807672 |
| Chaudhry SI et al. | A rash on the back. Diagnosis: confluent and reticulated papillomatosis (CRP) of Gougerot and Carteaud. | 2006 | Clin. Exp. Dermatol. | pmid:16901326 |
| Gruber F et al. | Treatment of confluent and reticulated papillomatosis with azithromycin. | 1998 | Clin. Exp. Dermatol. | pmid:9894368 |
| Weckmann M et al. | Treatment with rhDNase in patients with cystic fibrosis alters in-vitro CHIT-1 activity of isolated leucocytes. | 2016 | Clin. Exp. Immunol. | pmid:27324468 |
| Iwamoto S et al. | The effect of azithromycin on the maturation and function of murine bone marrow-derived dendritic cells. | 2011 | Clin. Exp. Immunol. | pmid:22059997 |
| Buehring I et al. | Chronic sinusitis refractory to standard management in patients with humoral immunodeficiencies. | 1997 | Clin. Exp. Immunol. | pmid:9328124 |
| Iwamoto S et al. | Efficacy of azithromycin in preventing lethal graft-versus-host disease. | 2013 | Clin. Exp. Immunol. | pmid:23379441 |
| Sugiyama K et al. | Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. | 2007 | Clin. Exp. Immunol. | pmid:17302905 |
| Rotschild M et al. | Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin. | 2005 | Clin. Exp. Med. | pmid:16096858 |
| Jones S et al. | Trachoma in Far North Queensland: an example of poor population health practice. | 2013 | Clin. Experiment. Ophthalmol. | pmid:23145782 |
| Lockington D | Oral azithromycin and blepharitis: symptoms and signs improve, so where are the publications? | 2016 | Clin. Experiment. Ophthalmol. | pmid:27356302 |
| Shah SA et al. | Meibomian gland dysfunction: azithromycin and objective improvement in outcomes in posterior blepharitis. | 2016 | Clin. Experiment. Ophthalmol. | pmid:27314917 |
| Heriot WJ et al. | Ocular involvement in a patient with Legionella longbeachae 1 infection. | 2014 | Clin. Experiment. Ophthalmol. | pmid:24650007 |
| Al-Hity A and Lockington D | Oral azithromycin as the systemic treatment of choice in the treatment of meibomian gland disease. | 2016 | Clin. Experiment. Ophthalmol. | pmid:26441357 |
| Martinez MA et al. | Clinical and histologic features of azithromycin-induced liver injury. | 2015 | Clin. Gastroenterol. Hepatol. | pmid:25111234 |
| Frenck RW et al. | Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. | 2004 | Clin. Infect. Dis. | pmid:15034826 |
| Kaplan EL et al. | Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin). | 2001 | Clin. Infect. Dis. | pmid:11360224 |
| Griffith DE et al. | Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease. | 1996 | Clin. Infect. Dis. | pmid:8953085 |
| Hicks LA et al. | US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. | 2015 | Clin. Infect. Dis. | pmid:25747410 |
| Adachi JA et al. | Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. | 2003 | Clin. Infect. Dis. | pmid:14557959 |
| Adal KA et al. | Photo quiz. Bacillary angiomatosis. | 1995 | Clin. Infect. Dis. | pmid:7727641 |
| Bissessor M et al. | Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. | 2015 | Clin. Infect. Dis. | pmid:25537875 |
| Gagliotti C et al. | Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes. | 2006 | Clin. Infect. Dis. | pmid:16575736 |
| Chou HW et al. | Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study. | 2015 | Clin. Infect. Dis. | pmid:25409476 |
| Kain KC et al. | Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. | 2001 | Clin. Infect. Dis. | pmid:11418883 |
| Lisby G et al. | Bacteremia and meningitis caused by a macrolide-sensitive strain of Streptococcus pneumoniae during treatment with azithromycin. | 2001 | Clin. Infect. Dis. | pmid:11438918 |
| Taylor WR et al. | Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. | 1999 | Clin. Infect. Dis. | pmid:10028075 |
| Reichenbach J et al. | Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. | 2009 | Clin. Infect. Dis. | pmid:19874205 |
| Haggerty CL and Ness RB | Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. | 2007 | Clin. Infect. Dis. | pmid:17342647 |
| Stoner BP | Current controversies in the management of adult syphilis. | 2007 | Clin. Infect. Dis. | pmid:17342666 |
| Geisler WM | Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. | 2007 | Clin. Infect. Dis. | pmid:17342671 |
| Katz AR et al. | Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. | 2012 | Clin. Infect. Dis. | pmid:22184617 |
| Genton B and D'Acremont V | Evidence of efficacy is not enough to develop recommendations: antibiotics for treatment of traveler's diarrhea. | 2007 | Clin. Infect. Dis. | pmid:17479953 |
| Esposito S et al. | Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy. | 2006 | Clin. Infect. Dis. | pmid:16779748 |
| White AC | Treatment of Early Syphilis in HIV: What Do We Really Know? | 2017 | Clin. Infect. Dis. | pmid:28362951 |
| Chidambaram JD et al. | Mass antibiotic treatment and community protection in trachoma control programs. | 2004 | Clin. Infect. Dis. | pmid:15494901 |
| Kim YS et al. | A comparative trial of a single dose of azithromycin versus doxycycline for the treatment of mild scrub typhus. | 2004 | Clin. Infect. Dis. | pmid:15494910 |
| Halpern MT and Cifaldi MA | Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia? | 2004 | Clin. Infect. Dis. | pmid:15206068 |
| Shanks GD et al. | Single dose of azithromycin or three-day course of ciprofloxacin as therapy for epidemic dysentery in Kenya. Acute Dysentery Study Group. | 1999 | Clin. Infect. Dis. | pmid:10589921 |
| Kong FY et al. | Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. | 2014 | Clin. Infect. Dis. | pmid:24729507 |
| Falagas ME and Klempner MS | Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. | 1996 | Clin. Infect. Dis. | pmid:8722936 |
| Murphy GS et al. | Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994. | 1996 | Clin. Infect. Dis. | pmid:8722958 |
| Guchev IA et al. | Two regimens of azithromycin prophylaxis against community-acquired respiratory and skin/soft-tissue infections among military trainees. | 2004 | Clin. Infect. Dis. | pmid:15095213 |
| Martin DH et al. | Comparison of azithromycin and ceftriaxone for the treatment of chancroid. | 1995 | Clin. Infect. Dis. | pmid:8562752 |
| Ghaffar F et al. | Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. | 2000 | Clin. Infect. Dis. | pmid:11049764 |
| Kelley MA et al. | Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. | 2000 | Clin. Infect. Dis. | pmid:11049784 |
| Adachi JA et al. | Empirical antimicrobial therapy for traveler's diarrhea. | 2000 | Clin. Infect. Dis. | pmid:11049792 |
| Solera J et al. | Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. | 2001 | Clin. Infect. Dis. | pmid:11170962 |
| Liao CH et al. | Nutritionally variant streptococcal infections at a University Hospital in Taiwan: disease emergence and high prevalence of beta-lactam and macrolide resistance. | 2004 | Clin. Infect. Dis. | pmid:14727223 |
| Rennie RP and Ibrahim KH | Antimicrobial resistance in Haemophilus influenzae: how can we prevent the inevitable? Commentary on antimicrobial resistance in H. influenzae based on data from the TARGETed surveillance program. | 2005 | Clin. Infect. Dis. | pmid:16032558 |
| Frenck RW et al. | Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. | 2000 | Clin. Infect. Dis. | pmid:11073741 |
| Tseng AL et al. | Azithromycin-related ototoxicity in patients infected with human immunodeficiency virus. | 1997 | Clin. Infect. Dis. | pmid:8994766 |
| Dunne M et al. | A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus. | 2000 | Clin. Infect. Dis. | pmid:11073759 |
| Adimora AA | Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. | 2002 | Clin. Infect. Dis. | pmid:12353204 |
| Augenbraun MH | Treatment of syphilis 2001: nonpregnant adults. | 2002 | Clin. Infect. Dis. | pmid:12353205 |
| Gill DA et al. | Complete elimination is a difficult goal for trachoma programs in severely affected communities. | 2008 | Clin. Infect. Dis. | pmid:18194094 |
| Schwebke JR and Desmond RA | A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. | 2007 | Clin. Infect. Dis. | pmid:17173219 |
| Fogarty C et al. | Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. | 2000 | Clin. Infect. Dis. | pmid:10987733 |
| Eschenbach DA | Bacterial vaginosis: resistance, recurrence, and/or reinfection? | 2007 | Clin. Infect. Dis. | pmid:17173220 |
| Kuschner RA et al. | Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. | 1995 | Clin. Infect. Dis. | pmid:8527539 |
| Tribble DR et al. | Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. | 2007 | Clin. Infect. Dis. | pmid:17205438 |
| Casey JR and Pichichero ME | Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis. | 2005 | Clin. Infect. Dis. | pmid:15909262 |
| DuPont HL | Azithromycin for the self-treatment of traveler's diarrhea. | 2007 | Clin. Infect. Dis. | pmid:17205439 |
| Amábile-Cuevas CF et al. | Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes. | 2001 | Clin. Infect. Dis. | pmid:11249826 |
| Donowitz GR | Tissue-directed antibiotics and intracellular parasites: complex interaction of phagocytes, pathogens, and drugs. | 1994 | Clin. Infect. Dis. | pmid:7893881 |
| Verdon MS et al. | Pilot study of azithromycin for treatment of primary and secondary syphilis. | 1994 | Clin. Infect. Dis. | pmid:7811868 |
| Sykes A et al. | Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial. | 2009 | Clin. Infect. Dis. | pmid:19769536 |
| Keenan JD et al. | Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma. | 2012 | Clin. Infect. Dis. | pmid:22095569 |
| Kaplan EL et al. | Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. | 2006 | Clin. Infect. Dis. | pmid:17083011 |
| Sirinavin S et al. | Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers. | 2003 | Clin. Infect. Dis. | pmid:12942401 |
| Doern GV | Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. | 2001 | Clin. Infect. Dis. | pmid:11524718 |
| Rocha JL | Correct dose of azithromycin for patients scheduled to undergo dental procedures. | 2003 | Clin. Infect. Dis. | pmid:12955653 |
| Sánchez F et al. | Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia? | 2003 | Clin. Infect. Dis. | pmid:12746768 |
| Kong FY et al. | Reply to Deguchi et al. | 2016 | Clin. Infect. Dis. | pmid:26494824 |
| Benson CA | Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS. | 1994 | Clin. Infect. Dis. | pmid:8204776 |
| Kalonji LM et al. | Invasive Salmonella Infections at Multiple Surveillance Sites in the Democratic Republic of the Congo, 2011-2014. | 2015 | Clin. Infect. Dis. | pmid:26449951 |
| Keenan JD et al. | Childhood mortality in a cohort treated with mass azithromycin for trachoma. | 2011 | Clin. Infect. Dis. | pmid:21427395 |
| Choi EK and Pai H | Azithromycin therapy for scrub typhus during pregnancy. | 1998 | Clin. Infect. Dis. | pmid:9868680 |
| Katz AR et al. | Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016. | 2017 | Clin. Infect. Dis. | pmid:28549097 |
| Karlowsky JA et al. | Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). | 2003 | Clin. Infect. Dis. | pmid:12684907 |
| Cascio A et al. | Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. | 2002 | Clin. Infect. Dis. | pmid:11740701 |
| Walker J et al. | Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women. | 2013 | Clin. Infect. Dis. | pmid:23300236 |
| Horner PJ | Editorial Commentary: Mycoplasma genitalium and Declining Treatment Efficacy of Azithromycin 1 g: What Can We Do? | 2015 | Clin. Infect. Dis. | pmid:26240204 |
| Lau A et al. | The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis. | 2015 | Clin. Infect. Dis. | pmid:26240201 |
| Gray GC et al. | Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. | 1998 | Clin. Infect. Dis. | pmid:9455517 |
| Andersen SL et al. | Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. | 1998 | Clin. Infect. Dis. | pmid:9455524 |
| Buyck JM et al. | Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. | 2012 | Clin. Infect. Dis. | pmid:22573850 |
| Chia JK et al. | Azithromycin for the treatment of cat-scratch disease. | 1998 | Clin. Infect. Dis. | pmid:9455538 |
| Peterson J and Treadway G | Impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. | 1998 | Clin. Infect. Dis. | pmid:9455579 |
| Mena LA et al. | A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. | 2009 | Clin. Infect. Dis. | pmid:19438399 |
| Jensen JS | Single-dose azithromycin treatment for Mycoplasma genitalium-positive urethritis: best but not good enough. | 2009 | Clin. Infect. Dis. | pmid:19438400 |
| Phillips P et al. | Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program. | 2002 | Clin. Infect. Dis. | pmid:11774085 |
| Mitchell SJ et al. | Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. | 2006 | Clin. Infect. Dis. | pmid:16392078 |
| Koepke R et al. | Widespread Bordetella parapertussis Infections-Wisconsin, 2011-2012: Clinical and Epidemiologic Features and Antibiotic Use for Treatment and Prevention. | 2015 | Clin. Infect. Dis. | pmid:26113655 |
| Guerra LG et al. | Rapid response of AIDS-related bacillary angiomatosis to azithromycin. | 1993 | Clin. Infect. Dis. | pmid:8399879 |
| Noedl H et al. | Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. | 2006 | Clin. Infect. Dis. | pmid:17051490 |